Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

L.A. McKeown

December 09, 2024

News Conference News SCCT 2024

Incidental CAC Tied to Worse Outcomes in Systemic Inflammatory Diseases

Todd Neale

July 21, 2024

News Daily News

Rheumatoid Arthritis and Aortic Stenosis: A Plausible Link—Now What?

Shelley Wood

August 01, 2023

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

Increased ASCVD Risk With Inflammatory Bowel Disease Merits Team-Based Care

Caitlin E. Cox

December 08, 2020

News Daily News

Colchicine in the Crosshairs for Its High US Cost

Caitlin E. Cox

December 01, 2020

News Conference News SCCT 2019

Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women

Yael L. Maxwell

July 12, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Conference News AHA 2018

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

Yael L. Maxwell

November 16, 2018

News Conference News AHA 2018

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Caitlin E. Cox

November 13, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

Obesity Not Benign: Higher Risk of CVD Seen With Excess Weight

Michael O'Riordan

June 05, 2018

News Conference News ACC 2018

Inflammatory Bowel Disease May Up the Risk of MI, Especially in Young People

L.A. McKeown

March 09, 2018

News Daily News

New Heart Failure Cases Rising Among Older Adults, MI Survivors

L.A. McKeown

November 24, 2017

News Conference News EAS 2017

Is Atherosclerosis an LDL-Cholesterol or Immune Disease? The Answer May Be Both

Yael L. Maxwell

April 25, 2017

News Conference News AHA 2016

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Shelley Wood

November 13, 2016

News Industry News

FDA strengthens warning on NSAID labels

July 10, 2015

Advertisement

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

Incidental CAC Tied to Worse Outcomes in Systemic Inflammatory Diseases

Rheumatoid Arthritis and Aortic Stenosis: A Plausible Link—Now What?

Making the Case for Sex-Specific CVD Guidelines

Increased ASCVD Risk With Inflammatory Bowel Disease Merits Team-Based Care

Colchicine in the Crosshairs for Its High US Cost

Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Obesity Not Benign: Higher Risk of CVD Seen With Excess Weight

Inflammatory Bowel Disease May Up the Risk of MI, Especially in Young People

New Heart Failure Cases Rising Among Older Adults, MI Survivors

Is Atherosclerosis an LDL-Cholesterol or Immune Disease? The Answer May Be Both

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

FDA strengthens warning on NSAID labels

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content